NCT03162627 2026-04-15Selumetinib and Olaparib in Solid TumorsM.D. Anderson Cancer CenterPhase 1 Active not recruiting90 enrolled
NCT01364051 2026-04-13Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesNational Cancer Institute (NCI)Phase 1 Active not recruiting19 enrolled